Synthetic Kratom Products Now Unrecognizable From Traditional Leaf; Clinicians Warn of Third Wave of Potent Products

Why it matters

Psychiatrists at Dartmouth Medical School identify a critical shift from traditional kratom products to highly concentrated synthetic formulations that bear no resemblance to the original plant product. This evolution poses unprecedented clinical and public health challenges for emergency departments and addiction specialists.

The big picture

Kratom has evolved through three distinct waves: traditional leaf products, concentrated alkaloid extracts, and now synthetic formulations designed to maximize potency. Dr. Corneliu Stanciu, assistant professor of psychiatry, describes the current market as a "wild west" of unregulated, high-potency products. Kratom poisonings have surged 1,200% according to CDC data, driven largely by these newer formulations.

Key findings

• Third wave of kratom products "look absolutely nothing like kratom," according to Dartmouth researchers
• Synthetic products contain dramatically higher concentrations of alkaloids than traditional leaf
• Kratom poisonings have increased 1,200% driven by concentrated products
• Medical community largely unprepared for clinical recognition and treatment of kratom toxicity
• Synthetic formulations create novel overdose risks

What they say

Dr. Corneliu Stanciu: "I tried to put out some public education alerts and nobody was interested. Kratom poisonings have surged by 1,200%, according to a recent CDC report, aided by the third wave of kratom products, which look absolutely nothing like kratom."

Bottom line

**The emergence of unrecognizable synthetic kratom products fundamentally changed the substance from a botanical supplement to a high-potency opioid analog, with clinicians warning of fentanyl-level potency in some formulations.**